ONYX PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-08-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ONYX PHARMACEUTICALS INC, 10-Q, EX-10.32, 2000-08-07
Next: ON SITE SOURCING INC, DEFA14A, 2000-08-07



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ONYX
PHARMACEUTICALS, INC.'S UNAUDITED CONDENSED BALANCE SHEET DATED JUNE 30,
2000, AND UNAUDITED CONDENSED STATEMENT OF OPERATIONS FOR THE SIX MONTHS
ENDED JUNE 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          35,777
<SECURITIES>                                     3,981
<RECEIVABLES>                                    2,442
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                42,855
<PP&E>                                          13,018
<DEPRECIATION>                                   9,872
<TOTAL-ASSETS>                                  46,361
<CURRENT-LIABILITIES>                           11,217
<BONDS>                                          1,283
                                0
                                          0
<COMMON>                                            14
<OTHER-SE>                                      33,797
<TOTAL-LIABILITY-AND-EQUITY>                    46,361
<SALES>                                              0
<TOTAL-REVENUES>                                14,847
<CGS>                                                0
<TOTAL-COSTS>                                   16,030
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  92
<INCOME-PRETAX>                                  (242)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (242)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (242)
<EPS-BASIC>                                     (0.02)
<EPS-DILUTED>                                   (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission